IP Verse

Exelixis, Inc. V. Cipla Ltd. - 1:23-cv-00287

Explore the details of the Exelixis, Inc. V. Cipla Ltd. case under case number 1:23-cv-00287 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:23-cv-00287
Filing Date
Mar 16, 2023
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved in the Case

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Exelixis, Inc. -
Cipla Ltd. -

Patents Involved in the Case

This case involves 5 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Application NumberPatent Number
-US11098015B2
-US8877776B2
-US11298349B2
-US11091440B2
-US11091439B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Mar 16, 2023Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Exelixis, Inc. (twk) (Entered: 03/17/2023)PACER Document
Mar 16, 2023Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,877,776 B2; 11,091,439 B2; 11,091,440 B2; 11,098,015 B2; 11,298,349 B2. (twk) (Entered: 03/17/2023)PACER Document
Mar 16, 2023Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: February 3, 2023. Date of Expiration of Patent: U.S. Patent No. 8,877,776 expires on October 8, 2030; U.S. Patent Nos. 11,091,439, 11,091,440 and 11,098,015 expire on January 15, 2030; and U.S. Patent No. 11,298,349 expires on February 10, 2032. Thirty Month Stay Deadline: 8/3/2025. (twk) (Entered: 03/17/2023)PACER Document
Mar 16, 2023Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) (Entered: 03/17/2023)PACER Document
Mar 16, 2023COMPLAINT FOR PATENT INFRINGEMENT filed against Cipla Ltd., Cipla USA, Inc. ( Filing fee $ 402, receipt number ADEDC-4091291.) - filed by Exelixis, Inc. (Attachments: # 1 Exhibit A-E, # 2 Civil Cover Sheet)(twk) (Entered: 03/17/2023)PACER Document
Mar 20, 2023WAIVER OF SERVICE returned executed by Exelixis, Inc.: For Cipla USA, Inc. waiver sent on 3/20/2023, answer due 5/19/2023. (Raucci, Anthony) (Entered: 03/20/2023)PACER Document
Mar 20, 2023WAIVER OF SERVICE returned executed by Exelixis, Inc.: For Cipla Ltd. waiver sent on 3/20/2023, answer due 5/19/2023. (Raucci, Anthony) (Entered: 03/20/2023)PACER Document
May 4, 2023[SEALED] STIPULATION and [Proposed] Order to Stay All Proceedings by Exelixis, Inc.. (Raucci, Anthony) (Entered: 05/04/2023)PACER Document
May 4, 2023Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Cipla (EU Limited) for Cipla Ltd., Cipla USA, Inc. filed by Cipla Ltd., Cipla USA, Inc.. (Farnan, Kelly) (Entered: 05/04/2023)PACER Document
May 4, 2023ORDER: The case is ADMINISTRATIVELY CLOSED. The parties shall promptly notify the Court when the related proceedings have been resolved so that this case may be reopened and other appropriate action may be taken. Signed by Judge Richard G. Andrews on 5/4/2023. (nms) (Entered: 05/04/2023)PACER Document
May 4, 2023[SEALED] ORDER Granting 9 Stipulation and Proposed Order to Stay All Proceedings. Signed by Judge Richard G. Andrews on 5/4/2023.*This order has been emailed to local counsel. (nms) (Entered: 05/04/2023)PACER Document
May 5, 2023REDACTED VERSION of 9 Stipulation - by Exelixis, Inc.. (Raucci, Anthony) (Entered: 05/05/2023)PACER Document
Mar 22, 2023Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)PACER Document
Mar 16, 2023COMPLAINT FOR PATENT INFRINGEMENT filed against Cipla Ltd., Cipla USA, Inc. ( Filing fee $ 402, receipt number ADEDC-4091291.) - filed by Exelixis, Inc. (Attachments: # 1 Exhibit A-E, # 2 Civil Cover Sheet)(twk) (Entered: 03/17/2023)Attachment
Mar 16, 2023COMPLAINT FOR PATENT INFRINGEMENT filed against Cipla Ltd., Cipla USA, Inc. ( Filing fee $ 402, receipt number ADEDC-4091291.) - filed by Exelixis, Inc. (Attachments: # 1 Exhibit A-E, # 2 Civil Cover Sheet)(twk) (Entered: 03/17/2023)Attachment
Jun 13, 2024NOTICE requesting Clerk to remove Kevin M. Yurkerwich as co-counsel.. (Raucci, Anthony) (Entered: 06/13/2024)PACER Document
Jul 8, 2024STIPULATION of Dismissal Without Prejudice, by Exelixis, Inc.. (Raucci, Anthony) Modified on 7/9/2024 (nms). (Entered: 07/08/2024)PACER Document
Jul 9, 2024SO ORDERED Granting (D.I. 15 in 23-cv-287-RGA; D.I. 10 in 24-cv-565-RGA) Stipulation of Dismissal (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 7/9/2024. Associated Cases: 1:24-cv-00565-RGA, 1:23-cv-00287-RGA(nms) (Entered: 07/09/2024)PACER Document
Jul 10, 2024Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,877,776 B2; 11,091,439 B2; 11,091,440 B2; 11,098,015 B2; 11,298,349 B2. (Attachments: # 1 Order)(nms) (Entered: 07/10/2024)PACER Document